Literature DB >> 17905146

Thiazolidinediones, deadly sins, surrogates, and elephants.

John G F Cleland1, Stephen L Atkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17905146     DOI： 10.1016/S0140-6736(07)61488-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.

Authors:  Faiez Zannad; Wendy Gattis Stough; Raymond J Lipicky; Juan Tamargo; George L Bakris; Jeffrey S Borer; Maria de Los Angeles Alonso García; Samy Hadjadj; Wolfgang Koenig; Stuart Kupfer; Peter A McCullough; Ofri Mosenzon; Stuart Pocock; André J Scheen; Harald Sourij; Bart Van der Schueren; Christina Stahre; William B White; Gonzalo Calvo
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2016-04-03

Review 2.  The determinants of clinical outcome and clinical response to CRT are not the same.

Authors:  John G F Cleland; Stefano Ghio
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

3.  Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes.

Authors:  Robert Ratner; Jenny Han; Dawn Nicewarner; Irina Yushmanova; Byron J Hoogwerf; Larry Shen
Journal:  Cardiovasc Diabetol       Date:  2011-03-16       Impact factor: 9.951

Review 4.  The CD36-PPARγ Pathway in Metabolic Disorders.

Authors:  Loïze Maréchal; Maximilien Laviolette; Amélie Rodrigue-Way; Baly Sow; Michèle Brochu; Véronique Caron; André Tremblay
Journal:  Int J Mol Sci       Date:  2018-05-21       Impact factor: 5.923

Review 5.  Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes.

Authors:  Bernd Richter; Elizabeth Bandeira-Echtler; Karla Bergerhoff; Christian Lerch
Journal:  Vasc Health Risk Manag       Date:  2008

Review 6.  The use of expensive technologies instead of simple, sound and effective lifestyle interventions: a perpetual delusion.

Authors:  Silvia Carlos; Jokin de Irala; Matt Hanley; Miguel Ángel Martínez-González
Journal:  J Epidemiol Community Health       Date:  2014-06-24       Impact factor: 3.710
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.